Postpartum Care — MCQs

A 23-year-old primigravida patient, two days postpartum after a normal vaginal delivery and spontaneous placental delivery, presents with bloody vaginal discharge and no other symptoms. Physical examination reveals a sweetish-smelling bloody discharge on the vaginal walls and introitus. Sterile pelvic examination shows a soft, non-tender uterus. Vital signs are: pulse 78/min, BP 110/76 mm Hg, temperature 37°C, and respiratory rate 16/min. Her WBC count is 10,000 with predominant granulocytes. What is the most appropriate next step?

Q60Easy

Which of the following drugs is NOT used in the management of Postpartum Hemorrhage?

Postpartum Care Indian Medical PG Practice Questions and MCQs

Question 51: Immediately following delivery, the height of the uterus corresponds to which gestational week?

A. 32 weeks
B. 20 weeks (Correct Answer)
C. 25 weeks
D. 12 weeks

Explanation: **Explanation:** The correct answer is **20 weeks**. **1. Why 20 weeks is correct:** Immediately following the delivery of the placenta, the uterus undergoes rapid contraction and retraction to prevent postpartum hemorrhage. This process reduces the uterine size significantly. At this immediate postpartum stage, the fundus of the uterus is typically palpable at the level of the **umbilicus**. In obstetric landmarks, the umbilicus corresponds to the **20th week of gestation**. Over the next 24 hours, the uterus may actually rise slightly above the umbilicus due to the recovery of pelvic floor tone, but the immediate post-delivery position is at the umbilical level. **2. Why the other options are incorrect:** * **32 weeks (Option A):** This is the height of the uterus during the third trimester (roughly midway between the umbilicus and the xiphoid process). The uterus shrinks far below this level immediately after delivery. * **25 weeks (Option C):** This would be slightly above the umbilicus. While the uterus may reach this height a few hours after delivery if the bladder is full, it is not the standard immediate postpartum height. * **12 weeks (Option D):** At 12 weeks, the uterus is just beginning to become an abdominal organ, palpable at the symphysis pubis. The uterus does not reach this small size until approximately **2 weeks postpartum**. **3. Clinical Pearls for NEET-PG:** * **Rate of Involution:** The uterus descends at a rate of approximately **1 cm (one fingerbreadth) per day**. * **Pelvic Organ Status:** By the **end of the 2nd week**, the uterus becomes a pelvic organ and is no longer palpable abdominally. * **Complete Involution:** The uterus returns to its non-pregnant size by the end of **6 weeks (the puerperium)**. * **Weight Change:** The uterus weighs ~1000g immediately after delivery, ~500g at 1 week, and ~60g at 6 weeks.

Question 52: Which of the following is a recently approved drug for postpartum depression?

A. Brexanolone (Correct Answer)
B. Calpacizumab
C. Solriamfetol
D. Siponimod

Explanation: **Explanation:** **Brexanolone (Option A)** is the correct answer. It is a first-in-class medication specifically approved by the FDA for the treatment of **Postpartum Depression (PPD)**. **Medical Concept:** Brexanolone is a synthetic formulation of **allopregnanolone**, a major metabolite of progesterone. During pregnancy, allopregnanolone levels rise significantly and drop abruptly after childbirth. In women susceptible to PPD, this rapid withdrawal triggers depressive symptoms. Brexanolone acts as a **positive allosteric modulator of GABA-A receptors**, helping to stabilize the neuroendocrine imbalance. It is administered as a single 60-hour continuous intravenous infusion under medical supervision. **Analysis of Incorrect Options:** * **Caplacizumab (Option B):** An anti-von Willebrand factor humanized antibody used for the treatment of acquired Thrombotic Thrombocytopenic Purpura (aTTP). * **Solriamfetol (Option C):** A dopamine and norepinephrine reuptake inhibitor (DNRI) used to improve wakefulness in patients with narcolepsy or obstructive sleep apnea. * **Siponimod (Option D):** A sphingosine-1-phosphate (S1P) receptor modulator used for the treatment of secondary progressive multiple sclerosis (SPMS). **High-Yield Clinical Pearls for NEET-PG:** * **Zuranolone:** A newer, **oral** neuroactive steroid (also an allopregnanolone analogue) recently approved for PPD, offering a more convenient alternative to intravenous Brexanolone. * **Screening:** The **Edinburgh Postnatal Depression Scale (EPDS)** is the gold standard screening tool for PPD. * **Timing:** PPD typically occurs within 4 weeks to 6 months postpartum, unlike "Postpartum Blues," which is self-limiting and peaks at 3–5 days.

Question 53: What is the recommended treatment for an ovarian cyst in a postpartum patient?

A. Immediate removal (Correct Answer)
B. Removal after 2 weeks
C. Removal after 6 weeks
D. Removal after 3 months

Explanation: **Explanation:** The correct answer is **Immediate removal**. In the postpartum period, the risk of **ovarian torsion** increases significantly. During pregnancy, the enlarging uterus displaces the ovaries out of the pelvis. Following delivery, the sudden involution of the uterus creates a large space in the abdominal cavity, allowing the ovaries (especially those enlarged by cysts) to move freely. This increased mobility, combined with the laxity of the supporting ligaments (infundibulopelvic and broad ligaments), makes the ovary highly prone to twisting on its pedicle. **Why the other options are incorrect:** * **Options B, C, and D (Delayed removal):** Waiting for 2 weeks, 6 weeks, or 3 months is dangerous. The highest risk of torsion occurs in the immediate puerperium (first few days to weeks). Delaying surgery leaves the patient at risk for adnexal ischemia, necrosis, and peritonitis, which could necessitate a total salpingo-oophorectomy rather than a simple cystectomy. **Clinical Pearls for NEET-PG:** * **Incidence:** Ovarian torsion is most common in the **first trimester** and the **immediate postpartum period**. * **Diagnosis:** The gold standard for diagnosis is **Doppler Ultrasound**, which shows absent or diminished blood flow to the ovary (though presence of flow does not rule out intermittent torsion). * **Management:** If a cyst is detected postpartum, surgical intervention (usually laparoscopic cystectomy) should be performed promptly to preserve ovarian function. * **Dermoid Cysts:** These are the most common type of benign tumors prone to torsion in pregnancy and the puerperium due to their weight and sebaceous content.

Question 54: Following delivery, the uterus becomes a pelvic organ after approximately how many weeks?

A. 2 weeks (Correct Answer)
B. 4 weeks
C. 6 weeks
D. 8 weeks

Explanation: **Explanation:** The process of the uterus returning to its pre-pregnant state is known as **involution**. Immediately after delivery, the fundus of the uterus is palpable at the level of the umbilicus (approx. 20-week size). It then descends at a rate of roughly 1 cm (one fingerbreadth) per day. By the end of the **2nd week (10–14 days)**, the uterus has shrunk sufficiently to descend below the level of the symphysis pubis. At this point, it is no longer palpable abdominally and is officially considered a **pelvic organ**. **Analysis of Options:** * **Option A (2 weeks):** Correct. This marks the transition from an abdominal to a pelvic organ. * **Option B (4 weeks):** Incorrect. By this time, the uterus is well within the pelvis and approaching its near-normal size. * **Option C (6 weeks):** Incorrect. This marks the end of the **puerperium**. By 6 weeks, involution is complete, and the uterus has returned to its non-pregnant size (except for being slightly larger in multiparous women). * **Option D (8 weeks):** Incorrect. This is beyond the standard puerperal period. **High-Yield NEET-PG Pearls:** * **Weight changes:** The uterus weighs ~1000g immediately postpartum, ~500g at 1 week, ~300g at 2 weeks, and ~60g at 6 weeks. * **Lochia sequence:** Rubra (red, 1–4 days) → Serosa (pink/brown, 5–9 days) → Alba (white/yellow, 10–14 days). * **Clinical Sign:** If the uterus remains high and boggy (subinvolution), suspect retained products of conception or infection. * **Breastfeeding:** Stimulates oxytocin release, which accelerates the rate of uterine involution.

Question 55: A woman recovers from severe postpartum hemorrhage and subsequently complains of failure of lactation and menstruation. Which of the following findings is most likely to be observed?

A. Increased excretion of sodium (Correct Answer)
B. Water retention
C. Increased prolactin levels
D. Increased GnRH levels

Explanation: The clinical scenario describes **Sheehan Syndrome**, which is ischemic necrosis of the anterior pituitary gland following severe postpartum hemorrhage (PPH). ### **Explanation of the Correct Answer** In Sheehan Syndrome, the destruction of the anterior pituitary leads to **panhypopituitarism**. The loss of Adrenocorticotropic Hormone (ACTH) results in secondary adrenal insufficiency. * **Mechanism:** Decreased ACTH leads to low cortisol levels. Cortisol is essential for maintaining vascular tone and renal free water clearance. More importantly, the lack of ACTH (and sometimes associated mineralocorticoid deficiency in acute phases) leads to a decreased ability of the kidneys to retain sodium. * **Result:** This leads to **increased excretion of sodium** (hyponatremia), which is a classic biochemical finding in these patients. ### **Why Other Options are Incorrect** * **B. Water retention:** While hyponatremia occurs, it is due to sodium loss and an inability to excrete free water (due to compensatory ADH rise), but "increased excretion of sodium" is the more direct consequence of the hormonal failure in this context. * **C. Increased prolactin levels:** The anterior pituitary is destroyed; therefore, prolactin levels **decrease**, leading to the hallmark symptom of **failure of lactation**. * **D. Increased GnRH levels:** Due to the loss of Gonadotropins (FSH/LH), there is no negative feedback from estrogen/progesterone. While GnRH *might* theoretically rise, the primary pathology is the pituitary's inability to respond. However, in panhypopituitarism, the entire hypothalamic-pituitary axis is often dampened. ### **Clinical Pearls for NEET-PG** * **Earliest Sign:** Failure of lactation (agalactia) is usually the first clinical sign of Sheehan Syndrome. * **Most Common Sign:** Failure to resume menstruation (amenorrhea) due to gonadotropin deficiency. * **Diagnosis:** Growth Hormone (GH) deficiency is often the earliest biochemical abnormality, but the **Insulin Tolerance Test** is the gold standard for diagnosis. * **MRI Finding:** In the chronic stage, MRI typically shows an **"Empty Sella."**

Question 56: Puerperal pyrexia is defined as fever for 24 hours or more after childbirth if the temperature is more than which of the following values in degrees Fahrenheit?

A. 99
B. 99.5
C. 100
D. 100.4 (Correct Answer)

Explanation: ### Explanation **1. Understanding the Correct Answer (D: 100.4°F)** Puerperal pyrexia is defined as a temperature of **100.4°F (38°C)** or higher, occurring on any **two of the first ten days** postpartum, **excluding the first 24 hours**. The first 24 hours are excluded because a mild rise in temperature (reactionary pyrexia) is common due to the physical exertion of labor and dehydration. The standard threshold of 100.4°F is used globally (WHO and FIGO) to differentiate physiological postpartum changes from potential infections like puerperal sepsis, urinary tract infections, or mastitis. **2. Why Other Options are Incorrect** * **A (99°F) & B (99.5°F):** These values fall within the range of a low-grade fever or even normal diurnal variation. Labeling these as puerperal pyrexia would lead to massive over-diagnosis and unnecessary antibiotic use. * **C (100°F):** While 100°F is often considered the threshold for "fever" in general clinical settings, the specific obstetric definition for the puerperium requires the higher threshold of 100.4°F to account for the metabolic activity of lactation and post-delivery inflammatory responses. **3. NEET-PG High-Yield Pearls** * **Most Common Cause:** Puerperal sepsis (infection of the genital tract) is the leading cause. * **The "Rule of 24 Hours":** Fever within the first 24 hours is usually due to dehydration or atelectasis; fever *after* 24 hours is more likely infectious. * **Common Organisms:** *Streptococcus pyogenes* (most common historically), *Staphylococcus aureus*, and anaerobes (Bacteroides). * **Clinical Sign:** Foul-smelling lochia and a sub-involuted, tender uterus suggest endometritis (the most common manifestation of puerperal sepsis).

Question 57: All of the following are used in the management of PPH except?

A. Blood transfusion
B. Fresh frozen plasma (FFP)
C. Cryoprecipitate
D. Novo-7 (Eptacog alfa) (Correct Answer)

Explanation: **Explanation:** The management of Postpartum Hemorrhage (PPH) follows a stepwise approach focusing on resuscitation, uterine contraction (uterotonics), and correcting coagulopathy. **Why Option D is the Correct Answer:** **Novo-7 (Recombinant Factor VIIa)** is generally **not** recommended as a routine management tool for PPH. While it is a potent procoagulant, its use in PPH is considered "off-label" and is strictly reserved as a **last-resort measure** when all other medical, mechanical, and surgical interventions (like uterine artery embolization or hysterectomy) have failed. It carries a significant risk of arterial and venous thrombosis and requires adequate levels of fibrinogen and platelets to be effective. Therefore, in the context of standard PPH management protocols, it is the "except" option. **Analysis of Incorrect Options:** * **A. Blood Transfusion:** Essential for restoring oxygen-carrying capacity in patients with significant blood loss (usually initiated if Hb <7-8 g/dL or massive hemorrhage). * **B. Fresh Frozen Plasma (FFP):** Crucial for replacing clotting factors. In massive PPH, a 1:1:1 ratio (PRBC:FFP:Platelets) is often followed to prevent dilutional coagulopathy. * **C. Cryoprecipitate:** Used specifically to correct **hypofibrinogenemia**. Since fibrinogen is the first clotting factor to drop to critical levels in PPH, cryoprecipitate is a vital component of management. **Clinical Pearls for NEET-PG:** * **Definition of PPH:** Blood loss >500 ml (Vaginal) or >1000 ml (LSCS). * **First-line Uterotonic:** Oxytocin (10 units IM or 5 units slow IV). * **Drug of choice for PPH prophylaxis:** Oxytocin. * **Fibrinogen levels:** If fibrinogen levels drop below **200 mg/dL**, it is a strong predictor of severe PPH; this is when Cryoprecipitate is most indicated. * **Tranexamic Acid (TXA):** Should be administered within 3 hours of birth (WOMAN Trial) as part of early management.

Question 58: Peripartum cardiomyopathy occurs:

A. Within 24 hours
B. Within 7 days
C. Within 6 weeks
D. Within 6 months (Correct Answer)

Explanation: **Explanation:** **Peripartum Cardiomyopathy (PPCM)** is a rare but life-threatening form of heart failure that occurs toward the end of pregnancy or in the months following delivery. 1. **Why Option D is Correct:** According to the standard clinical definition (modified from the NHLBI/Rare Disease Workshop), PPCM is characterized by the development of heart failure with an ejection fraction (EF) typically <45% occurring in the **last month of pregnancy or within 5 months postpartum**. Therefore, the window of "within 6 months" encompasses the entire diagnostic period defined by the postpartum phase. 2. **Why Other Options are Incorrect:** * **Options A, B, and C:** While PPCM can certainly manifest within 24 hours, 7 days, or 6 weeks, these options are too restrictive. Limiting the diagnosis to these timeframes would exclude a significant number of patients who present with symptoms 2 to 5 months after delivery. The question asks for the broad clinical window in which this specific pathology occurs. 3. **NEET-PG High-Yield Pearls:** * **Diagnostic Criteria:** 1) Development of heart failure in the last month of pregnancy or first 5 months postpartum; 2) Absence of prior heart disease; 3) No other identifiable cause for heart failure; 4) Echocardiographic evidence of left ventricular systolic dysfunction (EF <45%). * **Risk Factors:** Advanced maternal age (>30), multiparity, multifetal gestation, and preeclampsia. * **Management:** Standard heart failure therapy (diuretics, beta-blockers). **Note:** ACE inhibitors and ARBs are contraindicated *during* pregnancy but are the mainstay *postpartum*. * **Prognosis:** About 50% of patients recover baseline ventricular function. However, there is a high risk of recurrence in subsequent pregnancies; if the EF has not normalized, future pregnancy is strongly discouraged.

Question 59: A 23-year-old primigravida patient, two days postpartum after a normal vaginal delivery and spontaneous placental delivery, presents with bloody vaginal discharge and no other symptoms. Physical examination reveals a sweetish-smelling bloody discharge on the vaginal walls and introitus. Sterile pelvic examination shows a soft, non-tender uterus. Vital signs are: pulse 78/min, BP 110/76 mm Hg, temperature 37°C, and respiratory rate 16/min. Her WBC count is 10,000 with predominant granulocytes. What is the most appropriate next step?

A. Currettage
B. Oral antibiotics
C. Reassurance (Correct Answer)
D. Order urinalysis

Explanation: This patient is presenting with a normal physiological process known as **Lochia Rubra**. ### **Explanation of the Correct Answer** Lochia is the vaginal discharge following childbirth, consisting of blood, mucus, and placental tissue. * **Lochia Rubra:** Occurs in the first 3–4 days postpartum. It is characterized by a red/bloody appearance and a characteristic **"fleshy" or sweetish odor**. * **Clinical Findings:** The patient is hemodynamically stable (BP 110/76, Pulse 78), afebrile, and has a non-tender uterus. A WBC count of 10,000 is within the normal range (though counts up to 20,000–25,000 can be physiological during the early puerperium). * Since all findings are physiological, the most appropriate management is **Reassurance**. ### **Why Other Options are Incorrect** * **A. Curettage:** Indicated for Secondary Postpartum Hemorrhage (PPH) caused by retained products of conception (RPOCs). This patient has normal discharge, not heavy bleeding, and a soft, non-tender uterus. * **B. Oral Antibiotics:** Indicated for Endometritis. However, endometritis typically presents with fever, uterine tenderness, and foul-smelling (putrid) lochia, all of which are absent here. * **D. Urinalysis:** Used to rule out UTI. While common postpartum, the patient has no urinary symptoms (dysuria, frequency) or systemic signs of infection. ### **High-Yield NEET-PG Pearls: Lochia Stages** | Stage | Duration | Composition | | :--- | :--- | :--- | | **Lochia Rubra** | Days 1–4 | Red; contains blood, fetal membranes, decidua. | | **Lochia Serosa** | Days 5–9 | Pinkish/Brown; contains leucocytes, cervical mucus. | | **Lochia Alba** | Days 10–14 | Yellowish-white; contains decidual cells, fat, mucus. | * **Key Distinguisher:** Normal lochia has a "fleshy" odor. A **foul/putrid smell** is the most reliable early sign of puerperal sepsis.

Question 60: Which of the following drugs is NOT used in the management of Postpartum Hemorrhage?

A. Oxytocin
B. Methyl ergometrine
C. Mifepristone (Correct Answer)
D. Carboprost

Explanation: **Explanation:** The management of Postpartum Hemorrhage (PPH) focuses on achieving uterine contraction (uterotonics) to compress the spiral arteries. **Why Mifepristone is the correct answer:** **Mifepristone** is a competitive **progesterone receptor antagonist**. Its primary clinical uses include medical abortion (in combination with Misoprostol), cervical ripening, and management of Cushing’s syndrome. It does not possess acute uterotonic properties and, therefore, has no role in the emergency management of active PPH. **Why the other options are incorrect:** * **Oxytocin (Option A):** The first-line drug for both prophylaxis and treatment of PPH. It acts on G-protein coupled receptors to increase intracellular calcium, causing rhythmic uterine contractions. * **Methylergometrine (Option B):** An ergot alkaloid that causes tetanic uterine contractions. It is highly effective but **contraindicated in hypertensive patients** (including Preeclampsia/Eclampsia). * **Carboprost (Option C):** A synthetic analogue of PGF2α (15-methyl PGF2α). It is a potent uterotonic used when first-line agents fail. It is **contraindicated in patients with asthma** due to its bronchoconstrictive effects. **High-Yield Clinical Pearls for NEET-PG:** * **Misoprostol (PGE1):** Often used for PPH (600–800 mcg sublingually/rectally) due to its stability at room temperature. * **Contraindication Summary:** * *Methylergometrine:* Avoid in Hypertension. * *Carboprost:* Avoid in Asthma. * **Active Management of Third Stage of Labor (AMTSL):** The most important step to prevent PPH is the administration of 10 IU of Oxytocin (IM/IV) immediately after the birth of the baby.

Practice by Chapter

Normal Puerperium

Practice Questions

Lactation and Breastfeeding

Practice Questions

Postpartum Complications

Practice Questions

Postpartum Depression and Psychiatric Disorders

Practice Questions

Contraception After Delivery

Practice Questions

Postpartum Infections

Practice Questions

Secondary Postpartum Hemorrhage

Practice Questions

Recovery After Cesarean Delivery

Practice Questions

Postpartum Exercise and Rehabilitation

Practice Questions

Follow-up and Future Pregnancy Planning

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free